Vijay A, Gertz MA. Waldenström macroglobulinemia. Blood. 2007;109:5096–103. https://doi.org/10.1182/blood-2006-11-055012.

Article  CAS  PubMed  Google Scholar 

Swerdlow SH. International agency for research on C WHO classification of tumours of haematopoietic and lymphoid tissues Lyon. Int Agency Res Cancer. 2017;23:232–5.

Google Scholar 

Naderi N, Yang DT. Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia. Arch Pathol Lab Med. 2013;137:580–5. https://doi.org/10.5858/arpa.2012-0034-RS.

Article  CAS  PubMed  Google Scholar 

Gertz MA. Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management. Am J Hematol. 2015;90:346–54. https://doi.org/10.1002/ajh.23922.

Article  CAS  PubMed  Google Scholar 

Haraguchi S, Tomiyoshi Y, Aoki S, Sakemi T. Nephrotic syndrome due to immunologically mediated hypocomplementic glomerulonephritis in a patient of Waldenström’s macroglobulinemia. Nephron. 2002;92:452–5. https://doi.org/10.1159/000063286.

Article  PubMed  Google Scholar 

Uppal NN, Monga D, Vernace MA, Mehtabdin K, Shah HH, Bijol V, Jhaveri KD. Kidney diseases associated with Waldenström macroglobulinemia. Nephrol Dial Transplant. 2019;34:1644–52. https://doi.org/10.1093/ndt/gfy320.

Article  CAS  PubMed  Google Scholar 

Vos JM, Gustine J, Rennke HG, Hunter Z, Manning RJ, Dubeau TE, Meid K, Minnema MC, Kersten MJ, Treon SP, Castillo JJ. Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes. Br J Haematol. 2016;175:623–30. https://doi.org/10.1111/bjh.14279.

Article  CAS  PubMed  Google Scholar 

Banwait R, Aljawai Y, Cappuccio J, McDiarmid S, Morgan EA, Leblebjian H, Roccaro AM, Laubach J, Castillo JJ, Paba-Prada C, Treon S. Extramedullary Waldenström macroglobulinemia. Am J Hematol. 2015;90:100–4. https://doi.org/10.1002/ajh.23880.

Article  PubMed  Google Scholar 

Cao X, Medeiros LJ, Xia Y, Wang X, Thomas SK, Loghavi S, Li X, Shah JJ, Gustafson SA, Weber DM, Miranda RN. Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression. Leuk Lymphoma. 2016;57:1104–13. https://doi.org/10.3109/10428194.2015.1096357.

Article  CAS  PubMed  Google Scholar 

Kim S, Bae W, Choi J, Lee TW, Song DH, Bae E, Jang HN, Chang SH, Park DJ. Acute kidney injury due to direct infiltration by lymphoplasmacytic lymphoma secreting IgG paraproteins: a case report. Medicine (Baltimore). 2022;101: e29449. https://doi.org/10.1097/md.0000000000029449.

Article  PubMed  Google Scholar 

Kyle RA, Treon SP, Alexanian R, Barlogie B, Björkholm M, Dhodapkar M, Lister TA, Merlini G, Morel P, Stone M, Branagan AR. Prognostic markers and criteria to initiate therapy in Waldenstrom’s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom’s Macroglobulinemia. Semin Oncol. 2003;30:116–20. https://doi.org/10.1053/sonc.2003.50038.

Article  PubMed  Google Scholar 

Dimopoulos MA, Kastritis E, Owen RG, Kyle RA, Landgren O, Morra E, Leleu X, García-Sanz R, Munshi N, Anderson KC, Terpos E. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus. Blood. 2014;124:1404–11. https://doi.org/10.1182/blood-2014-03-565135.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leblond V, Kastritis E, Advani R, Ansell SM, Buske C, Castillo JJ, García-Sanz R, Gertz M, Kimby E, Kyriakou C, Merlini G. Treatment recommendations from the Eighth International Workshop on Waldenström’s Macroglobulinemia. Blood. 2016;128:1321–8. https://doi.org/10.1182/blood-2016-04-711234.

Article  CAS  PubMed  Google Scholar 

Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L. MYD88 L265P somatic mutation in Waldenström’s macroglobulinemia. N Engl J Med. 2012;367:826–33. https://doi.org/10.1056/NEJMoa1200710.

Article  CAS  PubMed  Google Scholar 

Treon SP, Tripsas CK, Meid K, Warren D, Varma G, Green R, Argyropoulos KV, Yang G, Cao Y, Xu L, Patterson CJ. Ibrutinib in previously treated Waldenström’s macroglobulinemia. N Engl J Med. 2015;372:1430–40. https://doi.org/10.1056/NEJMoa1501548.

Article  CAS  PubMed  Google Scholar 

King RL, Gonsalves WI, Ansell SM, Greipp PT, Frederick LA, Viswanatha DS, He R, Kyle RA, Gertz MA, Kapoor P, Morice WG. Lymphoplasmacytic lymphoma with a non-IgM paraprotein shows clinical and pathologic heterogeneity and may harbor MYD88 L265P mutations. Am J Clin Pathol. 2016;145:843–51. https://doi.org/10.1093/ajcp/aqw072.

Article  CAS  PubMed  Google Scholar